Original: $8.88
-65%$8.88
$3.11The Story
-
Elimus VIP Power is a plant-based dietary supplement with epimedium and other herbs, for the sexual health of both men and women. It offers energy, increases the vitality and alertness of the body, as well as the libido of both men and women. It contains herbs that have been shown in studies to be effective in achieving better erections and greater sexual activityin men and in increasing sexual desire in women.
Tο Epimedium, also known as horny goat weed, is a plant of the Berberidaceae family and is a very powerful aphrodisiac. In traditional Chinese medicine, epimedium is considered to have a beneficial effect on male potency. Its properties are due to its main ingredient, icariin. The herbal composition of VIP Power helps to dilate the cardiovascular vessels in the penis of men and in women it increases blood flow to the vagina, which facilitates sexual function. (The above product information is the result of studies. It is not an EFSA opinion.)
Details & Craftsmanship
Every detail has been carefully considered to bring you the perfect product.
Description
-
Elimus VIP Power is a plant-based dietary supplement with epimedium and other herbs, for the sexual health of both men and women. It offers energy, increases the vitality and alertness of the body, as well as the libido of both men and women. It contains herbs that have been shown in studies to be effective in achieving better erections and greater sexual activityin men and in increasing sexual desire in women.
Tο Epimedium, also known as horny goat weed, is a plant of the Berberidaceae family and is a very powerful aphrodisiac. In traditional Chinese medicine, epimedium is considered to have a beneficial effect on male potency. Its properties are due to its main ingredient, icariin. The herbal composition of VIP Power helps to dilate the cardiovascular vessels in the penis of men and in women it increases blood flow to the vagina, which facilitates sexual function. (The above product information is the result of studies. It is not an EFSA opinion.)
